foto

Prof. dr. S.E. Geerlings

Position
Scientific staff member (UD)
Main activities
Patient care, Research, Teaching
Specialisation
infectious diseases
Focus of research

urinary tract infections, quality of antibiotic use, quality of care

Main applicant and projectleader of the following studies:

1. Non-antibiotic versus antibiotic prophylaxis for recurrent urinary tract infections (NAPRUTI)-study (granted by the Netherlands Organisation for Health Research and Development).

2, (Cost)-Effectiveness of two different strategies to improve the quality of antibiotic use in patients with urinary tract infections (granted by the Netherlands Organisation for Health Research and Development). 

3. Development of generic quality indicators for the optimalisation of antibiotic use in the hospital  (granted by the Netherlands Organisation for Health Research and Development). 

4. Optimalization of quality of care for HIV-infected patients in care in HIV treatment centres the Netherlands.
(Granted by Aidsfonds).

5. Optimal antibiotic use: an “antibiotic checklist” for all bacterial infections in the hospital (granted by Netherlands Organisation for Health Research and Development).

6.  Reduction inappropriate catheter use (granted by Netherlands Organisation for Health Research and Development).

7.  Choosing Wisely in the Emergency Room. (granted by the Netherlands Organisation for Health Research and Development).

 

 

Co-applicant and projectleader:  
1. Prevention preterm birth: Costs and effects of screening of healthy women with a singleton pregnancy for a short cervical length or asymptomatic bacteriuria.
Main applicant: Prof. Dr. B. W. Mol (granted by the Netherlands Organisation for Health Research and Development)
 

Member project group:

1. Novel strategies and tools for antimicrobial resistance sureveillance in Indonesia
(granted by Research Projects of the Scieintific Programme Indonesia – Netherlands (SPIN).

2. Comordity and Ageing with HIV.
(granted by Netherlands Organisation for Health Research and Development and Aidsfonds)

3. Provider- and Indicator-led Proactive Testing in Primary Care in a high Prevalence area to prevent Late Presentation: a pilot project
(granted by Aidsfonds)

4. Faesibility Analysis of Nasoduodenal Feces Administration to eradicate Resistant Enterobacteriaeceae (FANFARE).(granted by Dutch Kidney Foundation)

5. Assessing the (cost)effectiveness of recommended strategies to evaluate and improve the quality of antibiotic use in Antimicrobial Stewardship programs.(granted by the Netherlands Organisation for Health Research and Development)

6. Antibiotic prescribing and non-prescribing for possible urinary tract infection in nursing home residents (granted by the Netherlands Organisation for Health Research and Development). 

7.  Reducing the risk of catheter-associated urinary tract infections via a smartphone application for patients (granted by the Netherlands Organisation for Health Research and Development)
  
  

 

 

 

 

 

 

 



 

.

Key publications
  • Beerepoot MAJ, ter Riet G, Nys S, van der Wal WM, de Borgie CAJM, de Reijke TM, Prins JM, Koeijers J, Verbon A, Stobberingh E, Geerlings SE, Lactobacilli vs Antibiotics to Prevent Urinary Tract Infections A Randomized, Double-blind, Noninferiority Trial in Postmenopausal Women. ARCH INTERN MED 2012;172 (9):704-712 [PubMed]
  • Beerepoot MAJ, ter Riet G, Nys S, van der Wal WM, de Borgie CAJM, de Reijke TM, Prins JM, Koeijers J, Verbon A, Stobberingh E, Geerlings SE, Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women. ARCH INTERN MED 2011;171 (14):1270-1278 [PubMed]
  • Hermanides HS, Hulscher MEJL, Schouten JA, Prins JM, Geerlings SE, Development of quality indicators for the antibiotic treatment of complicated urinary tract infections: A first step to measure and improve care. CLIN INFECT DIS 2008;46 (5):703-711 [PubMed]
  • Kazemier BM, Koningstein FN, Schneeberger C, Ott A, Bossuyt PM, de Miranda E, Vogelvang TE, Verhoeven CJM, Langenveld J, Woiski M, Oudijk MA, van der Ven JEM, Vlegels MTW, Kuiper PN, Feiertag N, Pajkrt E, de Groot CJM, Mol BWJ, Geerlings SE, Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. LANCET INFECT DIS 2015;15 (11):1324-1333 [PubMed]
  • Spoorenberg V, Hulscher MEJL, Akkermans RP, Prins JM, Geerlings SE, Appropriate antibiotic use for patients with urinary tract infections reduces length of hospital stay. CLIN INFECT DIS 2014;58 (2):164-169 [PubMed]
All Publications
Curriculum Vitae

Suzanne Geerlings was born in Amsterdam in 1965. During her medical studies in the Academic Medical Center in Amsterdam (MD in 1993), she followed a summer course Clinical Epidemiology at the McMaster University in Hamilton, Ontario. In 2001 she obtained her Board Certifcation of Internal Medicine in Utrecht. In the same time she was president of the residents of the Dutch Internal Medicine Society.

She subspecialised in Infectious Diseases (registration 2004) and defended her PhD thesis in 2000 at the University of Utrecht on the topic “ Asymptomatic bacteriuria in women with diabetes mellitus” (co-promotor Dr. RP Stolk, Dr. W Gaastra, promotor: Prof. Dr. AIM Hoepelman). She received the SB ICAAC award in 2000 and the ONVZ Prevention Year award in 2002 for this research. She worked at the Vrije Universiteit Medical Center from 2001 till 2003. In May 2003 she returned to the AMC, became a staff member of the Division Infectious Diseases, and continued doing research in the field of urinary tract infections, besides teaching and patient care. She was copromotor of Ruby Meiland (June 2006, promotor Prof. AIM Hoepelman and Prof. RP Stolk) on the thesis: “Pathogenesis, diagnosis and consequences of bacteriuria in women with and without diabetes mellitus.” She was the main author of the first version and recently updated revision of the Dutch Working Party on Antibiotic Policy- guideline ‘Antimicrobial treatment of complicated urinary tract infections’ and member of the working groups for the guidelines: Urinary tract infections of the Dutch College of General Practitioners, the Netherlands Society for Urology and the Infectious Diseases Society of America. At this moment, she is projectleader of the different studies (see above) and member of the projectgroup in many other studies. Furthermore, she is director of the program for internal medicine residents since 2014 and chair of the advisory board of PREZIES (PREvalentie ZIEkenhuisinfecties door Surveillance, PREvalence Hospitalinfections through Surveillance). 

Since January 2014 she is head of the Internal Medicine trainnee and since 2015 professor in Internal medicine, in special Quality of care.

 

Research programmes

Urinary tract infections, Quality of antibiotic use, Qualtiy of care

Suzanne.Geerlings is an infectious disease specialist and staff member in the AMC. The subject of her thesis (2000) was “Asymptomatic bacteriuria in women with diabetes mellitus, for which she received two awards. At the moment she is participating in many projects mainly concerning urinary tract infections, HIV and quality of care, leader of three projects granted by the Netherlands Organisation for Health Research and Development and the Aidsfonds and member of several working groups for the development of (inter)national guidelines for the treatment of urinary tract infections or HIV.

Faculty
Prof. dr. S.E. Geerlings

PhD Students
Drs. S.J. Bogers MD
Drs. B.J. Laan
Drs. R. Singh
M.L. Terpstra
Drs. K.J.M. Verhaegh MSc
S.L. de Vroom
C. Schneeberger (UMCG)

Prof. dr. J.M. Prins (Optimization of Antibiotic Therapy and Treatment of HIV Infection)

Other research related activities
  • Contribution to guidelines and protocols, Urinary Tract Infection- and HIV- guideline and quality indicators
  • Membership of advisory board / Consultant, International UTI Commission Board
  • Membership of medical or scientific committee, Ministry of Health, Welfare and Sport, Citrienfonds/RIVM
  • Contribution to training of professionals, Netherlands Internal Medicine Association
  • Contribution to guidelines and protocols, Reviewer many (inter)national journals
  • Membership of medical or scientific committee, Ministry of Health, Welfare and Sport, Member Workgroup Vaccination, Health Council (Gezondheidsraad)
Current research funding
  • AMC
  • OM Pharma
  • Stichting AMC Foundation
  • St. Werkgroep Antibioticabeleid (SWAB)
  • UMC St. Radboud
  • ZonMw